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Table 1
12 month 24 m 36 m 48 m 60 m 72 m
MVA (group A); Cm2 1,60 1,64 1,67 1,59 1,54 1,52
MVA (group B) 1,64 1,56 1,54 1,64 1,51 1,47
PAPs (Group A); mmHg 35 32 36 38 34 37
PAPs (Group B) 30 30 30 31 33 31,5
www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMConclusions: Our analysis could suggest that PMB might be non-inferior to surgical
commissurotomy presenting with good post procedural outcomes and similar clinical
results. Therefore further larger clinical randomized studies are warranted.
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Background: OBJETIVE:assess the long-term clinical, echocardiographic and he-
modynamics effects of percutaneous mitral balloon valvuloplasty (PMV) on
patients(pts)with pulmonary hypertension(PHT).
Methods: PMV was performed in 157 consecutive pts. 47 (29,9%) had PHT deﬁned
as resting pulmonary artery systolic pressure (PAPs) > 50 mmHg at baseline (group
A), and 110 controls pts(70,1%) (group B). Pts were clinical and echocardiographicaly
evaluated immediately after procedure 6 months after and once per year thereafter.
Following endpoints were considered: restenosis(RS),mitral valve replacement
(MVR) or MBV requirement, or cardiovascular death. A logistic regression model
was adjusted to determine independent predictors for outcome. A value of p < 0.05
was considered signiﬁcant.
Results: Median follow-up was 48 months (Q25-75: 24-84). Group A pts aged
43,7 12 years; 89,3% (42 pts) were female; 23,4% pts had atrial ﬁbrillation (AF).
Median ES was 7(Q25-75: 5-9).No diferences on baseline characteristics, successJACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/Vasculachievement, RS and follow up symptoms between Groups were found. PMV
inmediate success was 76.6% in Group A and 80% in Group B (P¼NS).MVA
increased from 0,90 cm2 to 1,75 cm2. PAPs fell from 57,5 mmhg to 35 mmHg in
Group A and from 38 mmhg to 30 mmHg in Group B. Success was associated with
ES < 8 (p¼0.01) both in group A and B. Long term outcomes are shown in table 1.
There were 3 in hospital deaths and 3 deaths during follow-up. 10 pts required newPMV; 6 p RVM. RS at 60 months follow-up was associated with ES > 8 in both
groups, A (p¼ 0,03) B (p¼ 0,02).
Conclusions: PMV is a safe and effective technique for treating patients with mitral
stenosis and PHT. Despite a gradual MVA decrease, most patients remain asymp-
tomatic and PAPs values were stable in the long term follow up.Vascular Access and Intervention - Transradial
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Background: Percutaneous coronary intervention (PCI) by the transradial approach
(TRA) is increasing adopted in most countries with the advantage of fewer vascular
complications compared with the transfemoral approach (TFA). Women are associ-
ated with higher risk of bleeding and access site complications undergoing PCI. So we
performed this study to compare the effect of TRA vs. TFA in women patients.
Methods: From July,2006 to Aug,2011, 4755 women patients who have undergone
PCI with stent implantation were included in the analysis. The primary endpoint
was deﬁned as in-hospital net adverse clinical events (NACE), which was a composite
of all-cause death, myocardial infarction (MI), target vessel revascularization
(TVR), stroke and major bleeding. The secondary endpoint was deﬁned as major
adverse cardiovascular events (MACE) which included all-cause death, MI and TVR.
Propensity score (PS) matching was performed to minimize the baseline disparity.
Results: Among 4755 women patients, 3801 (80%) patients were in the TRA group,
and 954 (20%) were in the TFA group. 563 pairs matched after PS calculating. In
the PS-matched patients, the rates of in-hospital NACE (3.6% vs. 5.5%, p¼0.114), in-
hospital MACE (2.0% vs. 2.1%, p¼0.833) and 1 year MACE (5.3% vs. 5.5%,
p¼0.895) were similar between TRA and TFA, but major bleeding (1.6% vs. 3.6%,
p¼0.036) and access site complications (2.0% vs. 7.5%, p< 0.001) were both lower in
the TRA group than in the TFA group.
Conclusions: TRA did not reduce the in-hospital and 1 year adverse clinical outcomes
compared with TFA in the PS-matched women patients, but TRA was associated with
fewer access site complications and major bleeding.
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SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comBackground: A transradial (TR) approach for percutaneous coronary intervention
(PCI) signiﬁcantly reduces bleeding and vascular complications compared to the
transfemoral (TF) approach. However, many patients undergoing PCI return for repeat
procedures over time and limited data is available to guide the choice of TR vs TF
approach in these patients. The present study compared procedural success and
adverse outcomes of TR and TF approach in patients undergoing successive PCI
procedures.
Methods: Baseline clinical, procedural and outcome data for patients undergoing
successive ipsilateral TR or TF approach for PCI were compared. The primary
outcome was procedural success deﬁned as completion of PCI by ipsilateral TR.
Results: A total of 634 and 2195 patients underwent  2 PCI procedures by ipsilateral
TR and TF approach respectively. The baseline characteristics, procedural parameters,
clinical outcomes and vascular complications of the study group are shown in the
Table.2PCI 3PCI 4PCI
TR-All
(n¼634)
TF-ALL
(n¼ 2195)
RADIAL
(n¼509)
FEMORAL
(n¼ 1376)
RADIAL
(n¼96)
FEMORAL
(n¼569)
RADIAL
(n¼29)
FEMORAL
(n¼250)
Procedural parameters
Fluoro time, minutes (meanSD)
189 1710* 189 1711 199 179* 228 178*
Contrast volume, ml (meanSD) 19473 19975 19676 20278 18463 19266 18853 19461
Guides per patient (meanSD) 1.10.3 1.20.4* 1.20.3 1.20.5 1.10.2 1.10.3 1.10.2 1.10.3
Stent per patient (meanSD) 2.71.6 2.82.2 2.61.5 2.51.8 2.91.8 3.12.4 3.31.8 3.41.7
Clinical outcomes
Procedural failure (%)
42 (7) 3 (0.1)* 33 (6) 2 (0.1)* 7 (7) 0 (0)* 2 (7) 1 (0.4)*
In hospital death (%) 0 (0) 6 (0.3) 0 (0) 2 (0.1) 0 (0) 3 (0.5) 0 (0) 1 (0.4)
Stroke (%) 0 (0) 10 (0.4) 0 (0) 6 (0.4) 0 (0) 2 (0.3) 0 (0) 2 (0.8)
Transfusion (%) 1 (0.2) 8 (0.4) 1 (0.2) 6 (0.4) 0 (0) 2 (0.3) 0 (0) 0 (0)
D eGFR (meanSD) 718 623 617 519 1019 725 618 532
Access site complications
Bleeding (%)
2 (0.3) 20 (0.9) 2 (0.4) 13 (0.9) 0 (0) 7 (1.2) 0 (0) 0 (0)
Pseudoaneurysm (%) 0 (0) 22 (1) * 0 (0) 18 (1.3) * 0 (0) 4 (0.7) 0 (0) 0 (0)
Any vascular complication (%) 12 (1.9) 88 (4) * 10 (2) 66 (4.8) * 2 (2.1) 19 (3.3) 0 (0) 3 (1.2)
CABG-coronary artery bypass surgery, MACE-major adverse cardiac events, D eGFR-increase in estimated glomerular ﬁltration rate post procedure, *p<0.05Conclusions: Successive ipsilateral TR approach can be accomplished in more than
90% of patients undergoing repeat PCI with no clinically important difference in
radiation exposure and contrast usage. In addition, TR approach results in a signiﬁ-
cantly lower risk of vascular complications and similar clinical outcomes compared to
the transfemoral approach. TR approach should be the preferred therapy for patients
undergoing repeat PCI.TCT-820
How to limit radial artery spasm in patients treated by transradial interventions
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Background: Radial artery spasm (RAS) remains the major limitation for transradial
approach, especially among transfemoralists physicians. Our team has performed three
successive randomized controlled trials sharing similar methodology and endpoints
and evaluating different vasodilator agents in the prevention of RAS. We are reporting
the results of the pooled analysis of our three studies.
Methods: A total of 1,950 patients were consecutively randomized to receive dilti-
azem, verapamil, molsidomine, isosorbide dinitrate (ISDN) or placebo, through the
arterial sheath after radial artery catheterization. The primary endpoint was the
occurrence of a RAS deﬁned as a limitation of the catheter movement and/or a sig-
niﬁcant pain perceived by the patient during catheter mobilization. Secondary end-
points included the occurrence of symptomatic or signiﬁcant fall of systolic blood
pressure and determination of independent predictors of RAS.
Results: RAS occurred in 44/198 patients (22.22 %) in the placebo group with a
signiﬁcant reduction in the molsidomine 27/203 (13.3%) and verapamil 88/847
(10.4%) group (P¼0.02). The rate of occurrence of RAS was similar between the
placebo, IDN and diltiazem groups (P¼0.2). Signiﬁcant fall of blood pressure
occurred signiﬁcantly more with diltiazem and ISDN compared to placebo or other
vasodilators (p¼0.001). Female gender and the use of more than 3 catheters were
identiﬁed as independent predictors of RAS.
Conclusions: Among vasodilators verapamil and/or molsidomine showed the best
efﬁcacy to prevent RAS without affecting patient safety. Their use reduces the
occurrence of RAS more than 50%. ISDN and diltiazem should be avoided as they
don’t prevent RAS.B240 JACC Vol 64/11/Suppl B j September 1TCT-821
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Background: The small proﬁle of a 4-Fr guiding catheter may reduce complications
associated with vascular access. In this study, we investigated the hypothesis whether
the use of a 4-Fr guiding catheter would have a lower rate of radial artery occlusion
compared with the use of a 6-Fr guiding catheter.
Methods: The study was conducted at 19 institutions across Asia. The frequency of
radial artery occlusion was compared between patients receiving 4-Fr vs. 6-Fr trans-
radial coronary interventions (TRI) in an open-label randomized trial (ClinicalTrials.
gov identiﬁer: NCT00815997). The primary outcome measure was radial artery oc-
clusion on the day after TRI. The secondary outcome measures were the procedural
success, major advanced cardiac events, access-site-related complications, procedural
times, ﬂuoroscopy times, and contrast dye usage.
Results: The present study comprised a total of 160 patients divided into 2 groups,
those who underwent 4-Fr TRI and those who underwent 6-Fr TRI. The procedure
was successful in 79 of 80 patients (99%) in both groups. While the 4-Fr group
showed no access-site-related complications, the 6-Fr developed 5 (6%), including 3
radial artery occlusions and 2 bleedings (1 radial artery perforation and 1 massive
hematoma) (p¼0.02). Although the radial artery occlusion rate was lower in the 4-Fr
vs. in the 6-Fr groups, the difference was not signiﬁcant (0% vs. 4%, p¼0.08). The
mean hemostasis time was signiﬁcantly shorter in the 4-Fr than in the 6-Fr groups (237
 105 min vs. 320  238 min, p¼0.007).
Conclusions: The current study demonstrates that 4-Fr TRI could deliver procedural
success rates that are comparable to 6-Fr TRI, with shorter times to hemostasis and
fewer access-site-related complications. Furthermore, 4-Fr TRI may reduce radial
artery occlusions. Hence, these ﬁndings suggest that 4-Fr PCI may provide a less
invasive approach to treat coronary artery diseases.TCT-822
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Background: The use of compression of the other artery [(COOA):ulnar compression
for radial access and vice versa], could increase access artery diameter(AAD)(via
collateral ﬂow through palmar arch) thus reducing puncture failure in small arteries,
which is a major challenge of transradial access in women; another being risk
of >1:1mismatch of small AADs with sheath size and consequent AA spasm. We
aimed to assess AADs (bilateral RA&UA); prevalence of a ‘single largest’
AA(with remaining 3AAs being smaller by >0.2mm(>0.1mm in 1.5mm group)) in
various size groups, in females compared to males; comparison of crossover, proce-
dure failure & AA occlusion (at 4 weeks)in < 1.7mm vs 1.7mm AAD groups; and
impact of COOA on puncture failures in patients with single largest AAD¼ 1.5,1.6 or
1.7mm.
Methods: AADs were measured using pre-procedure ultrasound (PPUAA). COOA
(for 5 minutes) was randomly utilized at the time of elective procedures, in 50%
patients in whom the single largest AAD was 1.5, 1.6 or 1.7mm. 1.5mm arteries were
used for coronary angiogram(CAG);1.6mm were used for percutaneous coronary
intervention(PCI).
Results: A total of 1110 patients: 264 females (F) & 846 males (M) were enrolled.
The baseline mean AADs(mm) were larger in males (1.820.2(radial(RA)),1.78-
0.2(ulnar(UA)) vs 1.710.2(RA),1.600.2(UA))(p< 0.001). Females more often
had only one largest AAD in the 1.5mm ((17.1%(F) vs 7.8%(M),1.6mm (9.6% (F) vs
3.8% (M)) and 1.7mm groups (10.6% (F) vs 4.5% (M) groups (p< 0.001). Again,
females more commonly had single largest AA in the 1.8-2.0mm group ( 42.8% (F) vs
29.7% (M), p< 0.001). With COOA, the AAD increased by 16.6+6%; 14.53%
&124.2% in the 1.5,1.6 &1.7mm groups respectively and puncture success was 78%
vs 98%(p< 0.001), 88% vs 97.8% (P< 0.001) and 96.7% vs 98.5%(p¼0.06) with and
without COOA respectively. Crossover (&procedure failure)& AA occlusion were
3.9% vs 0.9% & 2.8% vs 0.8% respectively (p< 0.0001) in the < 1.7mm vs 1.7mm
AAD groups.
Conclusions: Females more commonly have only one large AA, compared to
men. In the 1.5-1.6mm AAs, the use of COOA reduces puncture failures. Smaller
AAs(< 1.7mm), are associated with higher cross-over, procedure failure & AA
occlusion.3–17, 2014 j TCT Abstracts/Vascular Access and Intervention - Transradial
